RxSight, Inc. (RXST)
- Sector
- Health Care
- Last price
- $4.54
- As of
Kresmion compiles this page from RXST's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
RxSight, Inc. (RXST): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-03.
See the full RXST dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for RXST on one page. Preview it with sample data, then open it live with a free account.
Preview the RXST dossierActive events for RXST
- mediumEarnings above estimates
Q3-2026: Beat consensus by 28.2%, EPS $-0.21 vs $-0.2924 estimate
- high13F: large increase
CITADEL ADVISORS LLC added +107% to RXST (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +4700% to RXST (2026Q2)
- high13F: large increase
RENAISSANCE TECHNOLOGIES LLC added +133% to RXST (2026Q2)
- mediumEarnings above estimates
Q2-2026: Beat consensus by 67.3%, EPS $-0.11 vs $-0.3365 estimate
FREE, NO ACCOUNT
Every event on RXST, as it fires
You are seeing 5 of 12 events recorded on RXST since 2026-06-05.
The five above landed across 3 days. The other 7 were recorded on 3 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
RXST positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC FundCUSIP 78349D107 · 2026Q2 | $14.6M | 0.01% |
| D. E. Shaw & Co., Inc. FundCUSIP 78349D107 · 2026Q2 | $9.6M | 0.01% |
| TWO SIGMA INVESTMENTS, LP FundCUSIP 78349D107 · 2026Q2 | $5.5M | 0.00% |
| Point72 Asset Management, L.P. FundCUSIP 78349D107 · 2026Q2 | $3.8M | 0.01% |
| CITADEL ADVISORS LLC FundCUSIP 78349D107 · 2026Q2 | $3.4M | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 78349D107 · 2026Q2 | $678K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, RXST
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
More data on RXST
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in RXST on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on RXST in the last 180 days.
Upstream: SEC EDGAR filings for RXST
Kresmion, "RxSight, Inc. (RXST) institutional holdings and SEC filings", data as of 2026-11-04, https://kresmion.com/research/RXST. Upstream data: SEC EDGAR filings for RXST.
Link to this data (HTML):
<a href="https://kresmion.com/research/RXST">RxSight, Inc. (RXST) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow RXST on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to RXST for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.